279 related articles for article (PubMed ID: 37833861)
41. Clinical Assessment of Cytokine Profiles and Haematological Parameters in Patients with Systemic Lupus Erythematosus: A Cross-Sectional Study from Saudi Arabia.
Aldakheel FM; Alshanqiti MA; Alduraywish SA; Alshammary AF; Dabwan KH; Syed R
Front Biosci (Landmark Ed); 2023 Dec; 28(12):358. PubMed ID: 38179775
[TBL] [Abstract][Full Text] [Related]
42. Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics.
Omdal R; Mellgren SI; Koldingsnes W; Jacobsen EA; Husby G
J Rheumatol; 2002 Mar; 29(3):482-6. PubMed ID: 11908560
[TBL] [Abstract][Full Text] [Related]
43. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity.
Ye L; Ji L; Wen Z; Zhou Y; Hu D; Li Y; Yu T; Chen B; Zhang J; Ding L; Du J; Huang Z
J Transl Med; 2014 Mar; 12():69. PubMed ID: 24629023
[TBL] [Abstract][Full Text] [Related]
44. IL-38: A novel cytokine in systemic lupus erythematosus pathogenesis.
Xu WD; Su LC; Liu XY; Wang JM; Yuan ZC; Qin Z; Zhou XP; Huang AF
J Cell Mol Med; 2020 Nov; 24(21):12379-12389. PubMed ID: 33079487
[TBL] [Abstract][Full Text] [Related]
45. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment.
López P; Gómez J; Prado C; Gutiérrez C; Suárez A
J Rheumatol; 2008 Aug; 35(8):1559-66. PubMed ID: 18597405
[TBL] [Abstract][Full Text] [Related]
46. Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients.
Fleischer V; Sieber J; Fleischer SJ; Shock A; Heine G; Daridon C; Dörner T
Arthritis Res Ther; 2015 Jul; 17(1):185. PubMed ID: 26183319
[TBL] [Abstract][Full Text] [Related]
47. Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention.
Aringer M; Smolen JS
Lupus; 2004; 13(5):344-7. PubMed ID: 15230290
[TBL] [Abstract][Full Text] [Related]
48. Inflammatory cytokine kinetics to single bouts of acute moderate and intense aerobic exercise in women with active and inactive systemic lupus erythematosus.
Perandini LA; Sales-de-Oliveira D; Mello S; Camara NO; Benatti FB; Lima FR; Borba E; Bonfa E; Roschel H; Sá-Pinto AL; Gualano B
Exerc Immunol Rev; 2015; 21():174-85. PubMed ID: 25825870
[TBL] [Abstract][Full Text] [Related]
49. Impact of IL-34, IFN-α and IFN-λ1 on activity of systemic lupus erythematosus in Egyptian patients.
Adel Y; Sadeq Y
Reumatologia; 2020; 58(4):221-230. PubMed ID: 32921829
[TBL] [Abstract][Full Text] [Related]
50. Association of interleukin-36α gene expression in Egyptian patients with systemic lupus erythematosus with organ involvement and disease activity.
Mohamed AE; Zaki HM; Hosny MM; Fouad MM; Moneim NHA
Egypt J Immunol; 2021 Apr; 28(2):75-84. PubMed ID: 34185456
[TBL] [Abstract][Full Text] [Related]
51. Increased serum APRIL differentially correlates with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Boghdadi G; Elewa EA
Rheumatol Int; 2014 Sep; 34(9):1217-23. PubMed ID: 24748505
[TBL] [Abstract][Full Text] [Related]
52. A glance on the role of IL-35 in systemic lupus erythematosus (SLE).
Bahadorian D; Faraj TA; Kheder RK; Najmaldin SK; Haghmorad D; Mollazadeh S; Esmaeili SA
Cytokine; 2024 Apr; 176():156501. PubMed ID: 38290255
[TBL] [Abstract][Full Text] [Related]
53. Vitamin D deficiency in patients with active systemic lupus erythematosus.
Borba VZ; Vieira JG; Kasamatsu T; Radominski SC; Sato EI; Lazaretti-Castro M
Osteoporos Int; 2009 Mar; 20(3):427-33. PubMed ID: 18600287
[TBL] [Abstract][Full Text] [Related]
54. Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1alpha-889 C/T polymorphism.
Parks CG; Pandey JP; Dooley MA; Treadwell EL; St Clair EW; Gilkeson GS; Feghali-Bostwick CA; Cooper GS
Hum Immunol; 2004 Jun; 65(6):622-31. PubMed ID: 15219382
[TBL] [Abstract][Full Text] [Related]
55. Correlations of Expression Levels of a Panel of Genes (
Uzrail AH; Assaf AM; Abdalla SS
Biomed Res Int; 2019; 2019():1703842. PubMed ID: 31871930
[TBL] [Abstract][Full Text] [Related]
56. Serum cytokine levels associated with myocardial injury in systemic lupus erythematosus.
du Toit R; Reuter H; Walzl G; Snyders C; Chegou NN; Herbst PG; Doubell AF
Rheumatology (Oxford); 2021 Apr; 60(4):2010-2021. PubMed ID: 33221897
[TBL] [Abstract][Full Text] [Related]
57. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
[TBL] [Abstract][Full Text] [Related]
58. CD19
Xiong H; Tang Z; Xu Y; Shi Z; Guo Z; Liu X; Tan G; Ai X; Guo Q
Adv Rheumatol; 2022 Dec; 62(1):48. PubMed ID: 36494762
[TBL] [Abstract][Full Text] [Related]
59. Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease.
Wakiya R; Ueeda K; Shimada H; Nakashima S; Kameda T; Miyatake N; Kato M; Miyagi T; Sugihara K; Mizusaki M; Mino R; Kadowaki N; Dobashi H
Clin Rheumatol; 2022 Nov; 41(11):3345-3353. PubMed ID: 35849246
[TBL] [Abstract][Full Text] [Related]
60. Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus.
Erazo-Martínez V; Tobón GJ; Cañas CA
Autoimmun Rev; 2023 Feb; 22(2):103262. PubMed ID: 36563771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
